Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Vanguard Total Stock Market Index Fund ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while Vanguard Total Stock Market Index Fund ETF trades at $381.48 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 1008.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | VTI | |
|---|---|---|
Market Cap | $2.28B | $2.30T |
Volume | 3,128,960 | 2,730,571 |
Sector | Health | — |
52-Week High | $15.46 | $384.30 |
52-Week Low | $1.39 | $311.68 |
Enterprise Value | $2.15B | — |
Typical Hold Time | — | 131 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTI trades at $381.03, down 0.39% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF maintains strong diversification across the U.S. equity market, though key financial ratios are not provided in the snapshot. Recent news highlights long-term growth potential and comparisons with similar funds like VOO.
The outlook for VTI remains positive given broad market exposure and low-cost structure, but risks include concentration in top holdings and market volatility. Analyst sentiment is generally favorable for long-term investors, emphasizing diversification benefits and historical performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
